These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30632703)

  • 1. Three inflammation-related genes could predict risk in prognosis and metastasis of patients with breast cancer.
    Zhao S; Shen W; Du R; Luo X; Yu J; Zhou W; Dong X; Gao R; Wang C; Yang H; Wang S
    Cancer Med; 2019 Feb; 8(2):593-605. PubMed ID: 30632703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a 4-mRNA metastasis-related prognostic signature for patients with breast cancer.
    Xie X; Wang J; Shi D; Zou Y; Xiong Z; Li X; Zhou J; Tang H; Xie X
    J Cell Mol Med; 2019 Feb; 23(2):1439-1447. PubMed ID: 30484951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
    Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
    Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patients.
    Nimmrich I; Sieuwerts AM; Meijer-van Gelder ME; Schwope I; Bolt-de Vries J; Harbeck N; Koenig T; Hartmann O; Kluth A; Dietrich D; Magdolen V; Portengen H; Look MP; Klijn JG; Lesche R; Schmitt M; Maier S; Foekens JA; Martens JW
    Breast Cancer Res Treat; 2008 Oct; 111(3):429-37. PubMed ID: 17965955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
    Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
    Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer.
    Liu Z; Yu B; Su M; Yuan C; Liu C; Wang X; Song X; Li C; Wang F; Ma J; Wu M; Chen D; Yu J; Yu Z
    BMC Med; 2023 Dec; 21(1):493. PubMed ID: 38087296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
    Liu Q; Wang Z; Kong X; Wang X; Qi Y; Gao R; Fang Y; Wang J
    DNA Cell Biol; 2020 Apr; 39(4):671-682. PubMed ID: 32040341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
    Han J; Choi YL; Kim H; Choi JY; Lee SK; Lee JE; Choi JS; Park S; Choi JS; Kim YD; Nam SJ; Nam BH; Kwon MJ; Shin YK
    Breast Cancer Res Treat; 2017 Jul; 164(1):41-56. PubMed ID: 28409241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and validation of a hypoxia-related gene signature to predict the prognosis of breast cancer.
    Qiu C; Wang W; Xu S; Li Y; Zhu J; Zhang Y; Lei C; Li W; Li H; Li X
    BMC Cancer; 2024 Apr; 24(1):402. PubMed ID: 38561760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points.
    Dang J; Xu G; Guo G; Zhang H; Shang L
    J Cancer Res Clin Oncol; 2024 May; 150(5):255. PubMed ID: 38750370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
    Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
    Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFB-induced factor homeobox 1 (TGIF) expression in breast cancer.
    Stürken C; Möbus V; Milde-Langosch K; Schmatloch S; Fasching PA; Rüschoff J; Stickeler E; Henke RP; Denkert C; Hanker L; Schem C; Vladimirova V; Karn T; Nekljudova V; Köhne CH; Marmé F; Schumacher U; Loibl S; Müller V
    BMC Cancer; 2021 Aug; 21(1):920. PubMed ID: 34391399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients.
    Parrella P; Barbano R; Pasculli B; Fontana A; Copetti M; Valori VM; Poeta ML; Perrone G; Righi D; Castelvetere M; Coco M; Balsamo T; Morritti M; Pellegrini F; Onetti-Muda A; Maiello E; Murgo R; Fazio VM
    Mol Cancer; 2014 Jun; 13():142. PubMed ID: 24897960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
    Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
    J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
    Sgroi DC; Chapman JA; Badovinac-Crnjevic T; Zarella E; Binns S; Zhang Y; Schnabel CA; Erlander MG; Pritchard KI; Han L; Shepherd LE; Goss PE; Pollak M
    Breast Cancer Res; 2016 Jan; 18(1):1. PubMed ID: 26728744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
    Linardou H; Kalogeras KT; Kronenwett R; Kouvatseas G; Wirtz RM; Zagouri F; Gogas H; Christodoulou C; Koutras AK; Samantas E; Pectasides D; Bafaloukos D; Fountzilas G
    Breast Cancer Res; 2012 Nov; 14(6):R145. PubMed ID: 23146280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
    Linardou H; Kalogeras KT; Kronenwett R; Alexopoulou Z; Wirtz RM; Zagouri F; Scopa CD; Gogas H; Petraki K; Christodoulou C; Pavlakis K; Koutras AK; Samantas E; Patsea H; Pectasides D; Bafaloukos D; Fountzilas G
    Anticancer Res; 2015 Jul; 35(7):4023-36. PubMed ID: 26124351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive value of a mRNA signature in peripheral T-cell lymphomas: A mRNA expression analysis.
    Tu J; Kuang Z; Xie X; Wu S; Wu T; Chen S
    J Cell Mol Med; 2021 Jan; 25(1):84-95. PubMed ID: 33259129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.